NCT04185129 Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications Status UNKNOWN Phase PHASE4
NCT04184284 Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life Conditions Status COMPLETED Phase N/A
NCT04182802 MRI and Lung Function Measures of Benralizumab Response in Asthma Status WITHDRAWN Phase N/A
NCT04181905 The Relationship Between Kinesiophobia, Physical Activity Level and Quality of Life in Asthma Patients Status UNKNOWN Phase N/A
NCT04181190 Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients Status COMPLETED Phase N/A
NCT04173442 Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy Status COMPLETED Phase N/A
NCT04167280 Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled Asthma Status COMPLETED Phase PHASE4
NCT04159558 Development and Evaluation of mHealth Solutions to Monitor and Involve Cardiometabolic Patients in Self-care Status UNKNOWN Phase NA
NCT04159519 A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab Status COMPLETED Phase PHASE4
NCT04154579 Arts & Health Education to Improve Health, Resilience, and Well-Being Status TERMINATED Phase NA
NCT04150341 Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response Status COMPLETED Phase PHASE2
NCT04142905 Is Asthma in Subjects With Obstructive Sleep Apnoea (OSA) Due to Dysanapsis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04129931 PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study Status COMPLETED Phase PHASE2